\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ sided\\ facial\\ droop\\ with\\ noted\\ drooling\\.\ \(0\)\
\-\ inr\\ 1\\.3\ \(0\)\
\-\ the\\ patient\\ was\\ anticoagulated\\,\\ then\\ continued\\ on\\ long\\-term\\ warfarin\\ therapy\\ with\\ goal\\ inr\\ of\\ 3\\.0\\.\ \(0\)\
\-\ \\â\\€\\¢\\ there\\ is\\ a\\ low\\-attenuating\\ mass\\ in\\ the\\ left\\ atrial\\ appendage\\.\\ this\\ is\\ most\\ suggestive\\ of\\ a\\ thrombus\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ the\\ trileaflet\\ aortic\\ valve\\ is\\ calcified\\ and\\ stenotic\\,\\ with\\ a\\ systolic\\ valve\\ area\\ of\\ 1\\.4\\-1\\.7cm\\^2\\.\ \(0\)\
\-\ \\â\\€\\¢\\ there\\ are\\ no\\ infective\\ vegetations\\ present\\ on\\ either\\ the\\ aortic\\ or\\ mitral\\ valves\\.\ \(0\)\
\-\ left\\ atrial\\ appendage\\ thrombus\ \(0\)\
\-\ infective\\ endocarditis\ \(3\)\
\-\ left\\ atrial\\ myxoma\ \(1\)\
\-\ papillary\\ fibroelastoma\ \(2\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 80\\ year\\-old\\ man\\ with\\ a\\ known\\ history\\ of\\ rate\\-controlled\\ atrial\\ fibrillation\\ and\\ aortic\\ stenosis\\ presented\\ one\\ week\\ prior\\ to\\ study\\ with\\ facial\\ droop\\.\ \(1\)\
\-\ the\\ initial\\ brain\\ mri\\ showed\\ scattered\\ lesions\\ consistent\\ with\\ thromboembolic\\ phenomena\\.\ \(0\)\
\-\ this\\ patient\\ had\\ suspected\\ thromboembolic\\ disease\\ with\\ a\\ cardiac\\ origin\\.\\ in\\ a\\ patient\\ of\\ this\\ age\\ and\\ with\\ his\\ history\\ of\\ atrial\\ fibrillation\\ and\\ aortic\\ stenosis\\,\\ left\\ atrial\\ thrombus\\ and\\ infective\\ endocarditis\\ were\\ high\\ on\\ the\\ differential\\ for\\ the\\ embolic\\ source\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ two\\ transthoracic\\ echocardiograms\\ \\(ttes\\)\\ evaluating\\ for\\ possible\\ endocarditis\\.\\ both\\ ttes\\ were\\ negative\\ for\\ atrial\\ thrombus\\,\\ and\\ neither\\ could\\ effectively\\ image\\ the\\ aortic\\ valve\\ due\\ to\\ the\\ high\\ level\\ of\\ valvular\\ calcification\\ present\\.\\ it\\ should\\ be\\ noted\\ that\\ tte\\ has\\ a\\ relatively\\ low\\ sensitivity\\ \\(high\\ false\\ negative\\ rate\\)\\ for\\ visualizing\\ left\\ atrial\\ appendage\\ thrombi\\ compared\\ to\\ tee\\ and\\ cardiac\\-gated\\ ct\\.\ \(0\)\
\-\ a\\ transesophageal\\ echocardiogram\\ was\\ bypassed\\ after\\ the\\ patient\\ was\\ deemed\\ not\\ to\\ be\\ a\\ good\\ surgical\\ candidate\\ \\(based\\ on\\ age\\ and\\ comorbidities\\)\\;\\ this\\ cardiac\\-gated\\ ct\\ scan\\ was\\ later\\ performed\\ instead\\ to\\ evaluate\\ for\\ the\\ embolic\\ source\\.\\ the\\ ct\\ scan\\ showed\\ no\\ evidence\\ of\\ infective\\ endocarditis\\,\\ but\\ did\\ reveal\\ a\\ filling\\ defect\\ within\\ the\\ left\\ atrial\\ appendage\\.\\ of\\ note\\,\\ single\\-phase\\ contrast\\ imaging\\ with\\ cardiac\\-gated\\ ct\\ can\\ have\\ a\\ falsely\\ positive\\ filling\\ defect\\ in\\ the\\ left\\ atrial\\ appendage\\,\\ especially\\ in\\ cases\\ of\\ atrial\\ fibrillation\\ when\\ the\\ atria\\ may\\ be\\ dilated\\ and\\/or\\ there\\ is\\ little\\ contractility\\ to\\ allow\\ adequate\\ contrast\\ mixing\\ within\\ the\\ appendage\\.\\ key\\ to\\ this\\ study\\ is\\ the\\ late\\-phase\\ imaging\\,\\ which\\ showed\\ contrast\\ filling\\ the\\ atrial\\ appendage\\ and\\ highlighting\\ the\\ presence\\ of\\ a\\ thrombus\\.\\ this\\ finding\\ was\\ pathognomonic\\.\\ \ \(0\)\
\-\ cardiac\\ tumors\\,\\ including\\ atrial\\ myxomas\\ and\\ papillary\\ fibroelastomas\\ \\(as\\ well\\ as\\ metastatic\\ disease\\)\\,\\ are\\ other\\ possibilities\\,\\ but\\ are\\ considerably\\ more\\ rare\\;\\ thus\\,\\ they\\ remain\\ low\\ on\\ the\\ differential\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ atrial\\:\\ 0\\.48313616931839215\ \(0\)\
\-\ appendage\\:\\ 0\\.3645613813808945\ \(0\)\
\-\ infective\\:\\ 0\\.2275401953178773\ \(0\)\
\-\ endocarditis\\:\\ 0\\.187748542335334\ \(0\)\
\-\ thrombus\\:\\ 0\\.1838629086252261\ \(0\)\
\-\ the\\:\\ 0\\.16569247850337868\ \(0\)\
\-\ aortic\\:\\ 0\\.15279701495998232\ \(0\)\
\-\ cardiac\\:\\ 0\\.1468162085126572\ \(0\)\
\-\ fibrillation\\:\\ 0\\.13271217292164025\ \(0\)\
\-\ ttes\\:\\ 0\\.1264734340099826\ \(0\)\
\-\ valve\\:\\ 0\\.10877661014482114\ \(0\)\
\-\ left\\:\\ 0\\.10790987796043179\ \(0\)\
\-\ thromboembolic\\:\\ 0\\.09853907879465756\ \(0\)\
\-\ droop\\:\\ 0\\.09455069170157247\ \(0\)\
\-\ filling\\:\\ 0\\.09186555984898229\ \(0\)\
\-\ and\\:\\ 0\\.0898802126538235\ \(0\)\
\-\ embolic\\:\\ 0\\.08529199154252692\ \(0\)\
\-\ of\\:\\ 0\\.08512074482001714\ \(0\)\
\-\ inr\\:\\ 0\\.08459865353143774\ \(0\)\
\-\ this\\:\\ 0\\.08152464078272274\ \(0\)\
\-\ showed\\:\\ 0\\.07901386683454142\ \(0\)\
\-\ source\\:\\ 0\\.07533128574420629\ \(0\)\
\-\ papillary\\:\\ 0\\.07369835695169338\ \(0\)\
\-\ with\\:\\ 0\\.06968585818207959\ \(0\)\
\-\ to\\:\\ 0\\.06919844946901517\ \(0\)\
\-\ was\\:\\ 0\\.06890438350062396\ \(0\)\
\-\ low\\:\\ 0\\.06806872621166207\ \(0\)\
\-\ high\\:\\ 0\\.06741972639691154\ \(0\)\
\-\ facial\\:\\ 0\\.06521119859734592\ \(0\)\
\-\ patient\\:\\ 0\\.06430559603780833\ \(0\)\
\-\ trileaflet\\:\\ 0\\.0632367170049913\ \(0\)\
\-\ bypassed\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ falsely\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ contractility\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ highlighting\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ myxomas\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ fibroelastomas\\:\\ 0\\.0604260590621923\ \(0\)\
\-\ ct\\:\\ 0\\.06021647176958196\ \(0\)\
\-\ stenosis\\:\\ 0\\.060158153689834744\ \(0\)\
\-\ rate\\:\\ 0\\.05992804266726024\ \(0\)\
\-\ for\\:\\ 0\\.05992481072169347\ \(0\)\
\-\ on\\:\\ 0\\.059712239205453085\ \(0\)\
\-\ fibroelastoma\\:\\ 0\\.05843186551564975\ \(0\)\
\-\ defect\\:\\ 0\\.058012744219197984\ \(0\)\
\-\ contrast\\:\\ 0\\.05763836214925091\ \(0\)\
\-\ vegetations\\:\\ 0\\.05688504882946933\ \(0\)\
\-\ echocardiograms\\:\\ 0\\.05688504882946933\ \(0\)\
\-\ mixing\\:\\ 0\\.05688504882946933\ \(0\)\
\-\ tee\\:\\ 0\\.05562120757285075\ \(0\)\
\-\ transesophageal\\:\\ 0\\.05562120757285075\ \(0\)\
\-\ visualizing\\:\\ 0\\.05455264501597405\ \(0\)\
\-\ is\\:\\ 0\\.05414461263046029\ \(0\)\
\-\ transthoracic\\:\\ 0\\.05362701402630821\ \(0\)\
\-\ considerably\\:\\ 0\\.05362701402630821\ \(0\)\
\-\ effectively\\:\\ 0\\.05281054963005175\ \(0\)\
\-\ tte\\:\\ 0\\.05281054963005175\ \(0\)\
\-\ deemed\\:\\ 0\\.05281054963005175\ \(0\)\
\-\ study\\:\\ 0\\.05274370534751551\ \(0\)\
\-\ thrombi\\:\\ 0\\.05208019734012778\ \(0\)\
\-\ comorbidities\\:\\ 0\\.05208019734012778\ \(0\)\
\-\ differential\\:\\ 0\\.051385317621966346\ \(0\)\
\-\ drooling\\:\\ 0\\.050261505203404014\ \(0\)\
\-\ phenomena\\:\\ 0\\.050261505203404014\ \(0\)\
\-\ disease\\:\\ 0\\.0497953354689667\ \(0\)\
\-\ atria\\:\\ 0\\.04974779352663251\ \(0\)\
\-\ age\\:\\ 0\\.04965007197515465\ \(0\)\
\-\ negative\\:\\ 0\\.048960712690117085\ \(0\)\
\-\ anticoagulated\\:\\ 0\\.04840191657392293\ \(0\)\
\-\ warfarin\\:\\ 0\\.04840191657392293\ \(0\)\
\-\ myxoma\\:\\ 0\\.04840191657392293\ \(0\)\
\-\ be\\:\\ 0\\.04812216875621273\ \(0\)\
\-\ valvular\\:\\ 0\\.04800569814071021\ \(0\)\
\-\ possibilities\\:\\ 0\\.04800569814071021\ \(0\)\
\-\ there\\:\\ 0\\.04720125364987709\ \(0\)\
\-\ scan\\:\\ 0\\.046919993592443844\ \(0\)\
\-\ neither\\:\\ 0\\.04601150459416766\ \(0\)\
\-\ stenotic\\:\\ 0\\.04572852916460581\ \(0\)\
\-\ are\\:\\ 0\\.045013492731653025\ \(0\)\
\-\ goal\\:\\ 0\\.04494294203729096\ \(0\)\
\-\ instead\\:\\ 0\\.04401731104762512\ \(0\)\
\-\ valves\\:\\ 0\\.04380400389710765\ \(0\)\
\-\ allow\\:\\ 0\\.04339612535111053\ \(0\)\
\-\ metastatic\\:\\ 0\\.043373927011240584\ \(0\)\
\-\ candidate\\:\\ 0\\.04320084665136867\ \(0\)\
\-\ mitral\\:\\ 0\\.04301091873183526\ \(0\)\
\-\ false\\:\\ 0\\.04264599577126346\ \(0\)\
\-\ noted\\:\\ 0\\.04193051983954012\ \(0\)\
\-\ echocardiogram\\:\\ 0\\.04165402996518823\ \(0\)\
\-\ key\\:\\ 0\\.04165402996518823\ \(0\)\
\-\ imaging\\:\\ 0\\.04156161459318731\ \(0\)\
\-\ were\\:\\ 0\\.040765807392277836\ \(0\)\
\-\ present\\:\\ 0\\.04058085819401849\ \(0\)\
\-\ sensitivity\\:\\ 0\\.040138090547949416\ \(0\)\
\-\ remain\\:\\ 0\\.04001539822260797\ \(0\)\
\-\ systolic\\:\\ 0\\.03977634227734192\ \(0\)\
\-\ evaluating\\:\\ 0\\.03977634227734192\ \(0\)\
\-\ in\\:\\ 0\\.039347345625167764\ \(0\)\
\-\ but\\:\\ 0\\.039107440297523804\ \(0\)\
\-\ little\\:\\ 0\\.038894910813083175\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.038894910813083175\ \(0\)\
\-\ adequate\\:\\ 0\\.0384929468881069\ \(0\)\
\-\ within\\:\\ 0\\.03642391132447918\ \(0\)\
\-\ thus\\:\\ 0\\.03632996744502564\ \(0\)\
\-\ scattered\\:\\ 0\\.03440760806894204\ \(0\)\
\-\ origin\\:\\ 0\\.03403852053304769\ \(0\)\
\-\ reveal\\:\\ 0\\.03326210870212985\ \(0\)\
\-\ either\\:\\ 0\\.032689623787035785\ \(0\)\
\-\ continued\\:\\ 0\\.032399888790467415\ \(0\)\
\-\ suspected\\:\\ 0\\.032399888790467415\ \(0\)\
\-\ suggestive\\:\\ 0\\.032200107371882024\ \(0\)\
\-\ relatively\\:\\ 0\\.032200107371882024\ \(0\)\
\-\ good\\:\\ 0\\.032160832845201374\ \(0\)\
\-\ compared\\:\\ 0\\.03196773023570367\ \(0\)\
\-\ calcified\\:\\ 0\\.031854399066971746\ \(0\)\
\-\ as\\:\\ 0\\.03177107595283692\ \(0\)\
\-\ especially\\:\\ 0\\.03127940138094262\ \(0\)\
\-\ 80\\:\\ 0\\.030844969315034904\ \(0\)\
\-\ evaluate\\:\\ 0\\.030748467495521292\ \(0\)\
\-\ history\\:\\ 0\\.03021488157090368\ \(0\)\
\-\ rare\\:\\ 0\\.02985084436381968\ \(0\)\
\-\ note\\:\\ 0\\.029767158010400748\ \(0\)\
\-\ tumors\\:\\ 0\\.02908131268181992\ \(0\)\
\-\ could\\:\\ 0\\.028762264653513014\ \(0\)\
\-\ based\\:\\ 0\\.028643360616133165\ \(0\)\
\-\ presence\\:\\ 0\\.028411501697382335\ \(0\)\
\-\ did\\:\\ 0\\.028366046220300294\ \(0\)\
\-\ dilated\\:\\ 0\\.028320886872206314\ \(0\)\
\-\ later\\:\\ 0\\.028298417045672992\ \(0\)\
\-\ including\\:\\ 0\\.028298417045672992\ \(0\)\
\-\ they\\:\\ 0\\.028253694726574897\ \(0\)\
\-\ calcification\\:\\ 0\\.028231441303238836\ \(0\)\
\-\ then\\:\\ 0\\.0279912557343386\ \(0\)\
\-\ or\\:\\ 0\\.027512111478308357\ \(0\)\
\-\ underwent\\:\\ 0\\.027239475497163605\ \(0\)\
\-\ possible\\:\\ 0\\.02679209863680149\ \(0\)\
\-\ week\\:\\ 0\\.026596318513108022\ \(0\)\
\-\ cases\\:\\ 0\\.026596318513108022\ \(0\)\
\-\ initial\\:\\ 0\\.026526474744249174\ \(0\)\
\-\ positive\\:\\ 0\\.026056332886691513\ \(0\)\
\-\ finding\\:\\ 0\\.025991698987980448\ \(0\)\
\-\ should\\:\\ 0\\.025801336396215152\ \(0\)\
\-\ no\\:\\ 0\\.025717400212027026\ \(0\)\
\-\ area\\:\\ 0\\.025616062060181705\ \(0\)\
\-\ known\\:\\ 0\\.02560084375458333\ \(0\)\
\-\ sided\\:\\ 0\\.025435611035432265\ \(0\)\
\-\ image\\:\\ 0\\.025288742503113873\ \(0\)\
\-\ brain\\:\\ 0\\.02465055405498899\ \(0\)\
\-\ his\\:\\ 0\\.02398144069400249\ \(0\)\
\-\ level\\:\\ 0\\.023885826275810696\ \(0\)\
\-\ when\\:\\ 0\\.023885826275810696\ \(0\)\
\-\ two\\:\\ 0\\.023482357897599126\ \(0\)\
\-\ performed\\:\\ 0\\.02339334305752332\ \(0\)\
\-\ presented\\:\\ 0\\.023058819009969277\ \(0\)\
\-\ due\\:\\ 0\\.022729644506297955\ \(0\)\
\-\ therapy\\:\\ 0\\.022719605495975802\ \(0\)\
\-\ lesions\\:\\ 0\\.022709581003388754\ \(0\)\
\-\ one\\:\\ 0\\.022639812552591045\ \(0\)\
\-\ evidence\\:\\ 0\\.02244425838799127\ \(0\)\
\-\ prior\\:\\ 0\\.02212397614464095\ \(0\)\
\-\ both\\:\\ 0\\.022050718549585974\ \(0\)\
\-\ more\\:\\ 0\\.0217129420572597\ \(0\)\
\-\ consistent\\:\\ 0\\.021440732931517572\ \(0\)\
\-\ man\\:\\ 0\\.020934174955500547\ \(0\)\
\-\ can\\:\\ 0\\.020750536788159753\ \(0\)\
\-\ most\\:\\ 0\\.020579000854517537\ \(0\)\
\-\ other\\:\\ 0\\.02053494179465116\ \(0\)\
\-\ diagnosis\\:\\ 0\\.020498438627539507\ \(0\)\
\-\ mri\\:\\ 0\\.02029749889406865\ \(0\)\
\-\ it\\:\\ 0\\.020241141385136593\ \(0\)\
\-\ may\\:\\ 0\\.019898923060589754\ \(0\)\
\-\ have\\:\\ 0\\.019753538723848357\ \(0\)\
\-\ had\\:\\ 0\\.019701418663151487\ \(0\)\
\-\ surgical\\:\\ 0\\.019218838832979854\ \(0\)\
\-\ after\\:\\ 0\\.019182609122899364\ \(0\)\
\-\ well\\:\\ 0\\.01914656778304629\ \(0\)\
\-\ has\\:\\ 0\\.018061762168493676\ \(0\)\
\-\ which\\:\\ 0\\.017980268969337684\ \(0\)\
\-\ that\\:\\ 0\\.017159867411393886\ \(0\)\
\-\ not\\:\\ 0\\.01561035224905564\ \(0\)\
\-\ mass\\:\\ 0\\.015104096063835256\ \(0\)\
